Biosecurity test of conjugated nanoparticles of chitosan-protoporphyrin IX-vitamin B9 for their use in photodynamic therapy
https://www.embs.org/tnb/wp-content/themes/movedo/images/empty/thumbnail.jpg
150
150
Transactions on NanoBioscience (TNB)
//www.embs.org/tnb/wp-content/uploads/sites/16/2022/06/ieee-tnb-logo2x.png
The main obstacle of Photodynamic Therapy (PDT) to damage and destroy abnormal cells is that most photosensitizers (Ps) have a highly hydrophobic nature with a tendency to aggregate in aqueous…
read more